Melinda VanRoey

1.8k total citations
21 papers, 1.4k citations indexed

About

Melinda VanRoey is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Melinda VanRoey has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Melinda VanRoey's work include CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (11 papers) and Virus-based gene therapy research (9 papers). Melinda VanRoey is often cited by papers focused on CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (11 papers) and Virus-based gene therapy research (9 papers). Melinda VanRoey collaborates with scholars based in United States, Germany and Finland. Melinda VanRoey's co-authors include Karin Jooss, Thomas C. Harding, Guang Huan Tu, Betty Li, Jianmin Fang, Andrew D. Simmons, Jingjing Qian, Alshad S. Lalani, Bo Luan and Kathryn Koprivnikar and has published in prestigious journals such as Nature Biotechnology, Cancer Research and Journal of Virology.

In The Last Decade

Melinda VanRoey

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melinda VanRoey United States 18 768 707 552 412 124 21 1.4k
Guang Huan Tu United States 9 599 0.8× 541 0.8× 520 0.9× 278 0.7× 60 0.5× 11 1.2k
Xiao‐Tong Song United States 17 1.0k 1.3× 491 0.7× 644 1.2× 391 0.9× 77 0.6× 47 1.5k
Roy Lau United States 20 957 1.2× 727 1.0× 1.3k 2.4× 406 1.0× 91 0.7× 33 2.0k
Edward J. Dunphy United States 16 483 0.6× 625 0.9× 600 1.1× 353 0.9× 111 0.9× 18 1.4k
Stanley Chaleff United States 7 468 0.6× 437 0.6× 679 1.2× 247 0.6× 76 0.6× 8 1.5k
Rafael Moreno Spain 20 636 0.8× 491 0.7× 257 0.5× 628 1.5× 175 1.4× 49 1.2k
Ikumi Katano Japan 18 482 0.6× 312 0.4× 934 1.7× 292 0.7× 118 1.0× 39 1.5k
Ines Beyer Germany 20 458 0.6× 579 0.8× 212 0.4× 402 1.0× 76 0.6× 32 1.2k
Zeng B. Zhu United States 24 552 0.7× 823 1.2× 387 0.7× 776 1.9× 157 1.3× 45 1.4k
Kerry Fisher United Kingdom 17 606 0.8× 650 0.9× 271 0.5× 748 1.8× 142 1.1× 28 1.3k

Countries citing papers authored by Melinda VanRoey

Since Specialization
Citations

This map shows the geographic impact of Melinda VanRoey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda VanRoey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda VanRoey more than expected).

Fields of papers citing papers by Melinda VanRoey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda VanRoey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda VanRoey. The network helps show where Melinda VanRoey may publish in the future.

Co-authorship network of co-authors of Melinda VanRoey

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda VanRoey. A scholar is included among the top collaborators of Melinda VanRoey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda VanRoey. Melinda VanRoey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Betty, Melinda VanRoey, Changyu Wang, et al.. (2009). Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors. Clinical Cancer Research. 15(5). 1623–1634. 153 indexed citations
2.
Li, Betty, Andrew D. Simmons, Carol Y. Lin, et al.. (2009). Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Clinical Immunology. 133(2). 184–197. 16 indexed citations
3.
Robinson, Michael J., Betty Li, Ying Ge, et al.. (2009). Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors. Journal of Virology. 83(8). 3450–3462. 34 indexed citations
4.
Li, Betty, et al.. (2008). Enhancement of the anti-tumor efficacy of a GM-CSF–secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside. Experimental Hematology. 36(3). 319–328. 15 indexed citations
5.
6.
Simmons, Andrew D., Марина Москаленко, Jianmin Fang, et al.. (2008). Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity. Cancer Immunology Immunotherapy. 57(8). 1263–1270. 47 indexed citations
7.
Li, Betty, Melinda VanRoey, Frédéric Triebel, & Karin Jooss. (2008). Lymphocyte Activation Gene-3 Fusion Protein Increases the Potency of a Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy. Clinical Cancer Research. 14(11). 3545–3554. 14 indexed citations
8.
Ganesh, Shanthi, Neeraja Idamakanti, Melinda VanRoey, et al.. (2007). Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice. Cancer Research. 67(9). 4399–4407. 83 indexed citations
9.
Fang, Jianmin, Andrew D. Simmons, Guang Huan Tu, et al.. (2007). An Antibody Delivery System for Regulated Expression of Therapeutic Levels of Monoclonal Antibodies In Vivo. Molecular Therapy. 15(6). 1153–1159. 84 indexed citations
10.
Li, Betty, Jianmin Lin, Melinda VanRoey, Maria Jure–Kunkel, & Karin Jooss. (2007). Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb. Clinical Immunology. 125(1). 76–87. 49 indexed citations
11.
Li, Betty, Melinda VanRoey, & Karin Jooss. (2007). Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy. Clinical Immunology. 123(2). 155–165. 33 indexed citations
12.
Simmons, Andrew D., Betty Li, Carol Y. Lin, et al.. (2007). GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action. Cancer Immunology Immunotherapy. 56(10). 1653–1665. 36 indexed citations
13.
Prell, Rodney A., et al.. (2006). The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration. Cancer Immunology Immunotherapy. 55(10). 1285–1293. 26 indexed citations
14.
Harding, Thomas C., Alshad S. Lalani, Bo Luan, et al.. (2006). AAV Serotype 8-Mediated Gene Delivery of a Soluble VEGF Receptor to the CNS for the Treatment of Glioblastoma. Molecular Therapy. 13(5). 956–966. 33 indexed citations
15.
Fang, Jianmin, Jingjing Qian, Thomas C. Harding, et al.. (2005). Stable antibody expression at therapeutic levels using the 2A peptide. Nature Biotechnology. 23(5). 584–590. 306 indexed citations
16.
Prell, Rodney A., et al.. (2005). Administration of IFN-α Enhances the Efficacy of a Granulocyte Macrophage Colony Stimulating Factor–Secreting Tumor Cell Vaccine. Cancer Research. 65(6). 2449–2456. 19 indexed citations
17.
Lin, Jianmin, Alshad S. Lalani, Thomas C. Harding, et al.. (2005). Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy Receptor. Cancer Research. 65(15). 6901–6909. 202 indexed citations
18.
Li, Yuanhao, Neeraja Idamakanti, Steve H. Thorne, et al.. (2005). Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models. Clinical Cancer Research. 11(24). 8845–8855. 22 indexed citations
19.
Ramesh, Nagarajan, et al.. (2004). Identification of Pretreatment Agents to Enhance Adenovirus Infection of Bladder Epithelium. Molecular Therapy. 10(4). 697–705. 34 indexed citations
20.
Lalani, Alshad S., Betty Chang, Scott S. Case, et al.. (2003). Anti-Tumor Efficacy of Human Angiostatin Using Liver-Mediated Adeno-Associated Virus Gene Therapy. Molecular Therapy. 9(1). 56–66. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang Huan Tu Breakdown of academic impact, for papers by Xiao‐Tong Song Breakdown of academic impact, for papers by Roy Lau Breakdown of academic impact, for papers by Edward J. Dunphy Breakdown of academic impact, for papers by Stanley Chaleff Breakdown of academic impact, for papers by Rafael Moreno Breakdown of academic impact, for papers by Ikumi Katano Breakdown of academic impact, for papers by Ines Beyer Breakdown of academic impact, for papers by Zeng B. Zhu Breakdown of academic impact, for papers by Kerry Fisher
Rankless by CCL
2026